Home Consent Form Library OncologyImmunotherapy

Oncology Template Tool

Free Immunotherapy Consent Form Template

Operational & Compliance DisclaimerDisclaimer: This template is a sample for operational and administrative purposes only. ConsentCollect is a software platform, not a law firm or a healthcare provider. Consult with qualified legal counsel and medical directors to ensure compliance with local regulations before deploying any clinical consent form.

Professional medical consent form template for Immunotherapy

Informed Consent for Cancer Immunotherapy (Checkpoint Inhibitors)

Patient Informed Consent Documentation

Patient and Treatment Information

Cancer Center / Clinic Name

Attending Oncologist

Patient Full Legal Name

Date of Birth

Medical Record Number (MRN)

Immunotherapy Drug Name

Planned Dosing Interval

Nature and Purpose of Immunotherapy

Immunotherapy is a type of cancer treatment that helps your own immune system fight the cancer. The most common type of immunotherapy uses drugs called immune checkpoint inhibitors. Checkpoints are proteins on immune cells that need to be turned on or off to start an immune response. Cancer cells sometimes use these checkpoints to hide from the immune system. Checkpoint inhibitors block these proteins, allowing your T-cells (immune cells) to recognize and attack cancer cells. The drug is administered as an intravenous (IV) infusion in an outpatient oncology clinic. A treatment course typically consists of multiple cycles spaced several weeks apart, continuing as long as the cancer responds and the side effects are manageable.

Immune-Related Adverse Events (irAEs) Disclosure

Because immunotherapy stimulates your immune system, it can cause your immune cells to attack healthy tissues and organs in your body. This can cause inflammation in any organ, leading to serious or life-threatening side effects called Immune-Related Adverse Events (irAEs). These side effects are different from chemotherapy side effects. They can occur at any time during treatment, or even months after treatment has stopped. Early detection and treatment of irAEs with high-dose corticosteroids (such as prednisone) is essential to prevent permanent organ damage. You must report any new or worsening symptoms to your oncology team immediately.

Material Risks and Potential Complications

Pneumonitis (lung inflammation): occurs in 2 to 5 percent of patients. Symptoms include new or worsening cough, shortness of breath, or chest pain. Can be life-threatening if untreated.

Colitis (colon inflammation): causes severe diarrhea, blood or mucus in stool, and abdominal pain. Can lead to bowel perforation.

Hepatitis (liver inflammation): usually detected by blood tests showing elevated liver enzymes, but can cause yellowing of the skin/eyes (jaundice), severe fatigue, or dark urine.

Endocrine issues (hormone gland inflammation): can affect the thyroid, pituitary, or adrenal glands, or cause new-onset type 1 diabetes. Symptoms include extreme fatigue, weight changes, mood swings, or severe headaches. Damage to these glands is often permanent, requiring lifelong hormone replacement medications.

Nephritis (kidney inflammation): detected by blood tests showing rising creatinine or reduced kidney function.

Infusion reactions: fever, chills, dizziness, or breathing difficulty during the infusion. Managed by slowing or stopping the infusion and giving allergy medications.

Common side effects: fatigue, skin rash, itching, joint pain, or mild nausea. These are usually mild and manageable.

Alternatives to Immunotherapy

Chemotherapy: drugs that target and kill rapidly dividing cells directly, carrying different side effects (hair loss, low blood counts).

Targeted therapy: drugs that block specific molecules needed for cancer growth, if the tumor has specific genetic mutations.

Radiation therapy or surgery: local treatments to shrink or remove tumors, if appropriate for the stage of cancer.

Palliative care: focusing on symptom control and quality of life without active cancer-directed treatment.

Corticosteroid Treatment Agreement

I understand that if I develop moderate to severe immune-related side effects (irAEs), my oncologist will stop the immunotherapy drug and start high-dose corticosteroid treatment (such as prednisone or methylprednisolone) to reduce the inflammation. I agree to take the steroids exactly as directed and understand that they must be tapered off slowly over several weeks. Stopping steroids too quickly can cause the side effects to return. I understand that steroids have their own side effects including mood changes, high blood sugar, increased infection risk, and fluid retention.

Right to Refuse

You have the right to refuse or discontinue immunotherapy at any time. The oncologist will explain the impact on your cancer treatment plan, which may include tumor growth or disease progression.

Patient Understanding and Questions

I confirm that I have read this document and understand the immunotherapy treatment, the unique risks of immune-related side effects (irAEs), the importance of early symptom reporting, and the alternative options. All my questions have been answered.

Language Access

If English is not your primary language, a qualified interpreter is available at no cost. Please inform staff before signing.

Copy of Consent Acknowledgment

I acknowledge that I have been offered a copy of this signed consent form.

Patient Authorization

I voluntarily consent to undergo cancer immunotherapy treatment. I authorize the administration of the checkpoint inhibitor drug cycles as prescribed. I agree to report any side effects immediately and to follow the steroid treatment protocol if required.

Signatures and Verification

Patient Signature

Oncologist Signature

Witness Signature

Date and Time of Consent

Document ID: CC-IMMUNOTHERAPY-CONSENT-FORM

Need to print or customize this template?

Download a clean PDF copy or customize it in our Free Consent Builder. No account required.

Looking for a complete clinical workflow?

Standard PDF consent forms still leave your practice exposed to malpractice disputes. If you want verified patient comprehension quizzes, automated signing order tracking, biometric signature seals, and direct Epic/Cerner EHR FHIR R4 integration, then upgrade to our full ConsentCollect App.

Free Document Schema Specifications

Template Classification:Immunotherapy Layout

Target File Format:Printable PDF / HTML Structure

Customization Capability:Fully Editable Text & Checklist Fields

Licensing & Rights:Free Personal & Practice-Wide Use

How to Use the Digital Immunotherapy Consent Template

The Immunotherapy document layout available on this page is a structured administrative schema designed for oncology practice managers, compliance coordinators, and healthcare operations teams. Informed consent form layout for cancer immunotherapy treatments, covering checkpoint inhibitor infusions, immune-related adverse events (irAEs), and corticosteroid treatment protocols.

Using the ConsentCollect Free Builder, administrative staff can import this immunotherapy schema and configure every field to match their specific facility requirements. The builder supports drag-and-drop field reordering, custom label editing, signature block layout control, and client-side PDF generation, with no coding knowledge required and no account needed.

Once the immunotherapy layout is finalized, it can be printed as a high-resolution paper document, embedded into a digital patient intake kiosk, or exported as a structured JSON payload for integration into an existing EHR or practice management system. Organizations running the full ConsentCollect App subscription gain access to verified comprehension tracking, automated signing sequence management, biometric signature seals, and FHIR R4 interoperability with Epic and Cerner platforms.

❓ Frequently Asked Questions

How do I import and configure this Immunotherapy document layout in the Free Builder?

Click the "Customize in Free Builder" button on this page. The form schema opens directly in the client-side ConsentCollect Free Builder canvas with all fields, sections, and signature blocks pre-loaded. You can then drag and drop additional fields, relabel any section header, swap placeholder text for your facility name and provider credentials, and rearrange the field order to match your clinic workflow, all without creating an account.

What document structure and field types does this Immunotherapy layout include?

This layout contains 12 structured sections covering patient identification fields, administrative intake data, and signature capture blocks. Practice managers and compliance officers can override any field label or placeholder value inside the builder to match their own intake schema.

Can I use this Immunotherapy template for my Oncology practice without a paid subscription?

Yes. The Free Advanced Form Builder is entirely public with no account required. You can open this immunotherapy layout, edit all fields, and export a print-ready PDF or copy the underlying JSON schema at no cost. A paid ConsentCollect App subscription unlocks additional workflow features such as encrypted transmission, timestamped audit logs, multi-party signing order, and direct FHIR R4 EHR integrations.

Does this page provide clinical, legal, or medical advice about immunotherapy procedures?

No. This page is an administrative document schema tool hosted by ConsentCollect, a B2B compliance software platform. The form layout is provided for operational and administrative configuration purposes only. ConsentCollect is not a law firm, healthcare provider, or clinical advisory service. Before deploying any consent document to patients, the finished form must be reviewed by your organization's qualified legal counsel and a licensed medical director to confirm compliance with applicable regulations in your jurisdiction.

How do I export, print, or integrate this Immunotherapy form schema into my EHR system?

After editing in the Free Builder, use the Export button to download a high-resolution PDF suitable for physical signature collection. Alternatively, copy the JSON schema payload for use in your own patient intake database or web application. Subscribers to the full ConsentCollect App can push finalized templates directly into Epic or Cerner workflows via a certified FHIR R4 integration layer without any manual re-entry.

How to Write a Immunotherapy Consent Form

Building a legally compliant and clinically sound consent document for immunotherapy requires including specific structural components. Based on the pattern of this form, your final document should contain the following sections:

Patient and Treatment Information

Establish a structured administrative block at the top of the document to record key identifying details. This includes fields for the patient's full name, date of birth, medical record number (MRN), the attending clinician or specialist, and the name of the facility or practice where the immunotherapy will occur.

Nature and Purpose of Immunotherapy

Provide a clear, plain-language description explaining the nature and clinical purpose of the immunotherapy procedure. Describe the steps involved in the process, the target areas of the body, and what the patient should expect during the course of the intervention.

Immune-Related Adverse Events (irAEs) Disclosure

Incorporate a dedicated risks section that lists the material risks and potential complications of immunotherapy. It is critical to mention both common clinical complications (such as localized irritation, bleeding, or infection) and rarer, more severe risks (like nerve injury, systemic reactions, or long-term complications) to ensure informed decision-making.

Material Risks and Potential Complications

Alternatives to Immunotherapy

Outline the reasonable medical and therapeutic alternatives to immunotherapy. This should cover non-surgical interventions, medication adjustments, active clinical surveillance, or the detailed implications of choosing no treatment at all.

Corticosteroid Treatment Agreement

Insert a formal patient declaration and authorization statement where the patient confirms they have read the document, understand the disclosures, had all their questions regarding immunotherapy answered, and voluntarily authorize the procedure.

Right to Refuse

Specify the voluntary nature of the consent, explaining that the patient has the right to refuse the immunotherapy procedure or withdraw their consent at any point prior to the intervention without affecting their future clinical care or relationship with the healthcare provider.

Patient Understanding and Questions

Language Access

Include a language access statement detailing the availability of qualified medical interpreters and auxiliary communication aids at no cost to ensure patients with limited English proficiency are fully informed.

Copy of Consent Acknowledgment

Patient Authorization

Signatures and Verification

Provide designated signature blocks for the patient (or legally authorized representative), the primary clinical provider, and an optional witness, including fields to capture the date, time, role declaration, and location or timestamp verification.

How to Collect Consent for Immunotherapy

To legally collect consent for a immunotherapy procedure, you should use ConsentCollect. ConsentCollect is designed specifically for this clinical workflow by coordinating multi-phase chemotherapy, radiation therapy, and clinical trial consent documentations. Utilizing ConsentCollect for your immunotherapy consent forms ensures that your facility adheres to FDA clinical trial guidelines and oncology practice informed consent standards.

Additionally, ConsentCollect's premium platform includes direct secure messaging within the signing portal, allowing patients to ask questions about drug toxicities and receive clarifications before signing. This removes the administrative burden of physical paper printouts and manual scanning while ensuring your oncology patient intake is fully compliant, legally binding, and backed by robust clinical audit trails.

Consent Form Moat